Sonoma Pharmaceuticals, Inc.

SNOA Nasdaq SEC CIK 1367083
Follow Sonoma Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2027 USD · US GAAP
Revenue, last quarter $7.2M +28% vs same quarter last year
Net income −$66K +87.6% vs same quarter last year
EPS, diluted −$0.01 +96.9% vs same quarter last year
Operating cash flow −$736K −15.9% vs same quarter last year
Revenue by quarter
$3.6M
$3.8M
$4M
$5.6M
$4.3M
$5.6M
$6.4M
$7.2M
Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27 Q2 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$10M$0$10M$20MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$19.5M$3.2K
FY25$14.3M$3.5K
FY24$12.7M$4.8K
FY23$13.3M−$5.2M
FY22$12.6M−$5.1M
FY21$18.6M−$4M
FY20$17.9M−$3.3M
FY19$19M−$11.8M
FY18$16.7M−$14.3M
FY17$12.8M$9.3M
FY16$9.4M−$10.2M
FY15$13.9M−$8.2M
FY14$13.7M$3.7M
FY13$15.5M−$5.4M
FY12$12.7M−$7.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2638%−12.6%0%
FY2538.2%−26%0%
FY2437.3%−36.9%0%
FY2333.7%−34.4%−38.8%
FY2231.6%−46.6%−40.3%
FY2135.2%−18.5%−21.2%
FY2045.3%−41.2%−18.5%
FY1946.8%−59.3%−62.2%
FY1843.9%−85.2%−86%
FY1744.2%−101.2%72.3%
FY1628.3%−157%−108.5%
FY1552.6%−48.1%−59.2%
FY1461.4%−44.3%27.3%
FY1369.5%−21.8%−35.1%
FY1268.4%−50.7%−57.5%
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0$5MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26−$4.1M
FY25−$168K
FY24−$2.4M
FY23−$6.4M
FY22−$4.4M
FY21−$3.6M
FY20−$4.8M
FY19−$11.8M
FY18−$12.6M
FY17−$8.6M
FY16−$9.1M
FY15−$6.8M
FY14−$5.4M
FY13$893K
FY12−$4.4M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sonoma Pharmaceuticals
  • Healthcare median
−150%−100%−50%0%50%100%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearSonoma PharmaceuticalsHealthcare median
FY260%−11.1%
FY250%−30.6%
FY240%−47%
FY23−38.8%−58%
FY22−40.3%−80.4%
FY21−21.2%−71.8%
FY20−18.5%−62.2%
FY19−62.2%−46.2%
FY18−86%−49.6%
FY1772.3%−45.9%
FY16−108.5%−36%
FY15−59.2%−37.8%
FY1427.3%−35.5%
FY13−35.1%−37.1%
FY12−57.5%−29.1%